Trial Shows Potential for Chemotherapy-free Treatment of HER2-positive Early Breast Cancer

This study is the first to use an adaptive design that tailors treatment in the neoadjuvant/adjuvant setting of patients with HER2-positive early...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials